Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The primary hyperoxalurias.
Bobrowski AE, Langman CB. Bobrowski AE, et al. Among authors: langman cb. Semin Nephrol. 2008 Mar;28(2):152-62. doi: 10.1016/j.semnephrol.2008.01.008. Semin Nephrol. 2008. PMID: 18359396 Review.
Clinical grand rounds: atypical hemolytic uremic syndrome.
Hodgkins KS, Bobrowski AE, Lane JC, Langman CB. Hodgkins KS, et al. Among authors: langman cb. Am J Nephrol. 2012;35(5):394-400. doi: 10.1159/000337954. Epub 2012 Apr 18. Am J Nephrol. 2012. PMID: 22517061 Free article.
Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria.
Brooks ER, Hoppe B, Milliner DS, Salido E, Rim J, Krevitt LM, Olson JB, Price HE, Vural G, Langman CB. Brooks ER, et al. Among authors: langman cb. Am J Nephrol. 2016;43(4):293-303. doi: 10.1159/000445448. Epub 2016 May 3. Am J Nephrol. 2016. PMID: 27161247 Free PMC article.
ALLN-177, oral enzyme therapy for hyperoxaluria.
Lingeman JE, Pareek G, Easter L, Pease R, Grujic D, Brettman L, Langman CB. Lingeman JE, et al. Among authors: langman cb. Int Urol Nephrol. 2019 Apr;51(4):601-608. doi: 10.1007/s11255-019-02098-1. Epub 2019 Feb 19. Int Urol Nephrol. 2019. PMID: 30783888 Free PMC article.
Pathophysiology and Treatment of Enteric Hyperoxaluria.
Witting C, Langman CB, Assimos D, Baum MA, Kausz A, Milliner D, Tasian G, Worcester E, Allain M, West M, Knauf F, Lieske JC. Witting C, et al. Among authors: langman cb. Clin J Am Soc Nephrol. 2021 Mar 8;16(3):487-495. doi: 10.2215/CJN.08000520. Epub 2020 Sep 8. Clin J Am Soc Nephrol. 2021. PMID: 32900691 Free PMC article.
Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria.
Hoppe B, Koch A, Cochat P, Garrelfs SF, Baum MA, Groothoff JW, Lipkin G, Coenen M, Schalk G, Amrite A, McDougall D, Barrios K, Langman CB. Hoppe B, et al. Among authors: langman cb. Kidney Int. 2022 Mar;101(3):626-634. doi: 10.1016/j.kint.2021.08.015. Epub 2021 Sep 2. Kidney Int. 2022. PMID: 34481803 Free article. Clinical Trial.
224 results